Skip to main content

Hockey Thomas Chabot and Matt Duchene ready to return to Ottawa Senators' lineup

Ottawa Senators defenceman Thomas Chabot celebrates his goal against the Detroit Red Wings during a game on Dec. 14, 2018.

Paul Sancya/The Associated Press

The Ottawa Senators expect to have top defenceman Thomas Chabot and centre Matt Duchene back in the lineup on Wednesday night against the visiting Colorado Avalanche.

Chabot, the club’s lone all-star, has missed the past eight games with a shoulder injury, while Duchene, the team’s second-leading scorer, missed the past three games on a west coast trip to be with his wife for the birth of their son.

The Senators are tied for last in the NHL after going 2-5-1 without Chabot.

Story continues below advertisement

“I think Duchene, it’s going to easier for him to come back … He should be jumping in there and doing his thing,” Senators coach Guy Boucher said. “For Chabot, he hasn’t played for a long time so let’s give him time to build it up. But yes over the next games and little while obviously, it changes so much for us.”

Top goalie Craig Anderson remains sidelined with a concussion, though Boucher said there is a chance he could return this weekend.

Report an error
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter